N/A
N=39
Ericksonian Hypnosis Versus CBT for Prolonged Grief
Prolonged Grief Symptoms
Bottom Line
View on ClinicalTrials.gov: NCT06398886 ↗Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Prolonged Grief Scale — 34; 21; 24; 26 points
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ericksonian Hypnosis (Behavioral); Cognitive Behavioral Therapy (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Istanbul Nisantasi University
- Primary completion
- Mar 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prolonged Grief Scale |
34; 21; 24; 26; 19; 18 | — |
| PRIMARY Beck Depression Inventory |
38.15; 25.54; 21.38; 33; 24.62; 16.77 | — |
Summary
Effects of Ericksonian Hypnotherapy Versus Cognitive Behavioral Therapy on Prolonged Grief Among University Students in Istanbul: A Randomized None-clinical Controlled Trial
This randomized controlled trial explores the efficacy of Ericksonian Hypnotherapy versus Cognitive Behavioral Therapy (CBT) in mitigating symptoms of prolonged grief among university students in Istanbul. With a backdrop of transitional academic and socio-emotional challenges, 39 students who experienced significant loss and exhibited symptoms of prolonged grief were enrolled. Participants were randomly assigned to undergo Ericksonian Hypnotherapy, CBT, or placed on a waiting list (control group), each with 13 individuals. The study uniquely positions itself in Istanbul, leveraging the city's cultural context to examine grief processing in an urban, academically engaged population. Utilizing the Prolonged Grief Scale, Beck Depression Inventory, and SCL-90 Symptom Checklist for assessment, the interventions were evaluated for their effectiveness in reducing grief and associated psychological symptoms.
Eligibility Criteria
Inclusion Criteria
- Age Range: Participants must be aged between 18 and 35 years.
- Loss Experience: Participants should have experienced the loss of someone significant.
- Grief Intensity: Participants must score 25 or above on the Prolonged Grief Scale (PG-13).
- Psychological Health: Participants should not exhibit other psychopathological symptoms, apart from those associated with grief, as measured by the Symptom Checklist-90 (SCL-90).
- Commitment to Participation: Participants must be able and willing to attend all 8 full sessions.
Exclusion Criteria
- Age Limitations: Individuals under 18 or older than 35 years are excluded.
- Psychiatric Health: Individuals with any psychiatric diagnosis or those who have been on psychiatric medication within the last year are excluded.
- Availability: Individuals who cannot commit to attending all 8 sessions are excluded.
Data sourced from ClinicalTrials.gov (NCT06398886). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.